Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care(TM)

PALO ALTO, Calif., Oct. 19, 2020 /PRNewswire/ -- Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care(TM) during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually from October 24-31. At this year's show, the company will showcase its progress in helping more people access advanced cancer care, making cancer care more personalized, and delivering more data-driven insights to improve efficiencies and outcomes. In addition to a "best in class" virtual experience, Varian's contributions to Intelligent Cancer Care will be highlighted in eleven presentations including data from the use of Varian's adaptive radiotherapy system, Ethos(®), for lung, prostate, bladder, upper abdomen, head & neck cancers, and the first-look data presented by the recently-formed AI-driven Adaptive Intelligence Consortium.

"Despite the transition to a virtual platform, our entire global Varian team is looking forward to connecting with ASTRO 2020 attendees and showcasing our innovations that help providers deliver the best cancer care to patients throughout their entire journey," said Dow Wilson, Chief Executive Officer of Varian. "Since its launch at last year's ASTRO, our Ethos(®) Therapy has demonstrated significant impact toward personalizing treatment for patients resulting in 10 featured presentations during this year's meeting."

At this year's virtual event, Varian will participate with a dynamic booth presence and provide one-on-one product demonstrations, as well as highlight how it pioneers for the future with sessions during the ASTRO Innovation Hub. The company will also have a presence at the American Society of Radiologic Technologists (ASRT) and Society of Radiation Oncology Administrators (SROA) concurrent meetings. Attendees can register for all Varian educational and demo sessions at https://www.varian.com/resources-support/events/virtual-events

ASTRO attendees will be able to view the following data presentations featuring Varian products and innovation. Registration links are available here: https://www.astro.org/Meetings-and-Education/Micro-Sites/2020/Annual-Meeting/Register

                   Topic 
      
              Session/Time and Day

    ---

        Brain Cancer        - Semi-Automated Hippocampal Sparing
                             Avoidance Whole-Brain Radiotherapy Using a
                             Commercially Available Artificial
                             Intelligence Toolkit                         
     Digital Poster Q&A

                                                                          
     
              Oct 25, 2:00 p.m. ET

    ---

        Upper               - Feasibility of AI-assisted CBCT-guided
         Abdomen             Stereotactic Online Adaptive Radiotherapy
         Cancer              (CT-STAR) for Upper Abdominal SBRT: Results
                             of a Prospective in Silico Clinical Trial    
     Oral Presentations

                                                                          
     
              Oct 25, 9:10 a.m. ET


                           - Evaluation and validation of artificial
                             intelligence (AI) delineation models for
                             CBCT-guided stereotactic online adaptive
                             radiotherapy (STAR) targeting upper
                             abdominal malignancies                       
     
              Oct 25, 12:20 a.m. ET





        Prostate            -Adaptive radiotherapy can be applied
         Cancer              routinely, using an artificial intelligence
                             solution, to treat prostate cancer patients  
     Digital Poster Q&A

                                                                          
     
              Oct 25, 2:15 p.m. ET

    ---

        Head & Neck         - Evaluation of dosimetric quality of auto-
         Cancer              generated plans by a novel online adaptive
                             system for head and neck radiotherapy        
     Digital Posters Q&A

                                                                          
     
              Oct 25, 2:15 p.m. ET


                            - Evaluation of the Auto-Segmentation
                             Performance of a Novel Online Adaptive
                             Radiotherapy System for Head and Neck Cancer
                             Treatment                                    
     
              Oct 25, 2:15 p.m. ET


                            -Head and neck quad shot using CT based
                             adaptive treatment on a ring gantry LINAC    
     
              Oct 26, 4:30 p.m. ET



        AI and              - First AI-driven Adaptive System-
         Cancer              International Consortium lead Failure Mode
         Treatment           and Effect Analysis (FMEA)                   
     Oral Presentation

                                                                          
     
              Oct 26, 12:50 a.m. ET

    ---

        Bladder             - Results of a pilot study on online
         Cancer              adaptive radiotherapy of bladder cancer with
                             artificial intelligence-driven full re-
                             optimization on the anatomy of the day       
     Oral Presentation

                                                                          
     
              Oct 27, 1:00 a.m. ET

    ---

        Lung Cancer         -Improved treatment quality in stage III
                             lung cancer patients using online adaptive
                             radiotherapy in a simulation setting         
     Digital Poster Q&A

                                                                          
     
              Oct 27, 2:00 p.m. ET

    ---

        Treatment           - Accuracy of the Treatment Plan Dose
         Planning            Preview Functionality of a Newly
                             Commercially- Available, CBCT-Based,
                             Online Adaptive Radiotherapy Treatment
                             System                                       
     Digital Posters Q&A

                                                                          
     
              Oct 25, 2:15 p.m. ET


                            - Data-Driven Margin Determination for
                             Online Adaptive Radiotherapy Using Batch
                             Automated Planning                           
     
              Oct 25, 2:15 p.m. ET


                           - Plan quality and fidelity evaluation of
                             CBCT-Guided stereotactic online adaptive
                             radiotherapy (CT-STAR) with an artificial
                             intelligence (AI) aided plan re-
                             optimization                                 
     
              Oct 28, 2:00 p.m. ET



        Clinical            - Dosimetric Impact and Required Clinician
         Workflow            Time of Online Adaptive Radiotherapy using a
                             Newly Commercially-Available, CBCT-Based
                             Adaptive Treatment System                    
     Digital Poster Q&A

                                                                          
     
              Oct 25, 2:15 p.m. ET


                            -Feasibility of Expediting Radiotherapy
                             Clinical Workflow by Planning on Diagnostic
                             Images and Adapting on a Commercial Adaptive
                             Radiotherapy System                          
     Oral Presentation

                                                                          
     
              Oct 28, 3:15 p.m. ET


About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contacts
Aimee Corso
Health+Commerce
+1 (310) 780-2661
aimee@healthandcommerce.com

Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com

View original content:http://www.prnewswire.com/news-releases/varian-announces-presence-at-american-society-for-radiation-oncology-astro-annual-meeting-highlighting-advancements-in-intelligent-cancer-care-301154021.html

SOURCE Varian